Apogee director granted 2,741 deferred stock units

Alvord Christina M reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Alvord Christina M reported acquisition or exercise transactions in this Form 4 filing.

APOGEE ENTERPRISES, INC. director Christina M. Alvord received a grant of 2,741 deferred restricted stock units, valued at $41.96 per unit. These units were allocated under the 2019 Non-Employee Director Stock Plan and will be settled in common shares after she leaves the Board or upon specified plan events.

Each deferred restricted stock unit is settled 1-for-1 in common stock. Following this grant, Alvord now holds a total of 13,280 deferred restricted stock units, including amounts accumulated through a dividend equivalent reinvestment feature in the same director stock plan.

Insider Trade Summary

Grant/Award: 2,741 shares

Grant/Award 1 txn

Insider Alvord Christina M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferrred Restricted Stock Units	2,741	$41.96	$115K

Holdings After Transaction: Deferrred Restricted Stock Units — 13,280 contracts (Direct)

Footnotes (3)

1. F1. The deferred restricted stock units were allocated under the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person or following the occurrence of other events specified in the Plan.
2. F2. Settled 1-for 1.
3. F3. Includes deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2019 Non-Employee Director Stock Plan.

Key Figures

Deferred stock units granted: 2,741 units Grant reference price: $41.96 per unit Total deferred units after grant: 13,280 units +1 more

4 metrics

Deferred stock units granted 2,741 units Deferred restricted stock units awarded to director on June 24, 2026

Grant reference price $41.96 per unit Transaction price per deferred restricted stock unit

Total deferred units after grant 13,280 units Director’s total deferred restricted stock units following the transaction

Conversion ratio 1-for-1 Each deferred restricted stock unit settled into one common share

Key Terms

Deferred Restricted Stock Units, 2019 Non-Employee Director Stock Plan, dividend equivalent reinvestment feature

3 terms

Deferred Restricted Stock Units financial

"The deferred restricted stock units were allocated under the 2019 Non-Employee Director Stock Plan."

Deferred restricted stock units are promises by a company to give employees or executives company shares at a future date, subject to conditions like continued employment or performance targets; the delivery and tax event are intentionally delayed. They matter to investors because they affect when new shares may be issued and how executives are motivated—like a paycheck held in escrow that vests over time, influencing potential share dilution and management behavior.

2019 Non-Employee Director Stock Plan financial

"The deferred restricted stock units were allocated under the 2019 Non-Employee Director Stock Plan."

dividend equivalent reinvestment feature financial

"Includes deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2019 Non-Employee Director Stock Plan."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did APOG director Christina Alvord report on this Form 4?

Christina M. Alvord reported receiving 2,741 deferred restricted stock units. The units were granted under Apogee’s 2019 Non-Employee Director Stock Plan as part of director compensation, increasing her total deferred units position reported in this filing.

How many deferred restricted stock units does APOG’s Christina Alvord hold after this grant?

After the grant, Christina M. Alvord holds 13,280 deferred restricted stock units. This total includes the new 2,741-unit award and prior units accumulated, including those from the plan’s dividend equivalent reinvestment feature described in the filing footnotes.

At what reference price were Christina Alvord’s APOG deferred units valued in this grant?

The 2,741 deferred restricted stock units were valued at $41.96 per unit. This figure reflects the transaction price per unit used in the Form 4 and helps indicate the notional value of the compensation award for reporting purposes.

When will Christina Alvord’s APOG deferred restricted stock units be settled into common stock?

The deferred restricted stock units will be settled in common stock after Alvord’s termination from the Board. Settlement can also occur upon other events specified in the 2019 Non-Employee Director Stock Plan and according to her prior election choices.

How are APOG deferred restricted stock units converted into common shares for Christina Alvord?

Each deferred restricted stock unit is settled 1-for-1 into a share of common stock. This direct conversion ratio is disclosed in the footnotes, meaning 2,741 new units correspond to 2,741 future common shares upon settlement events.

What plan governs Christina Alvord’s APOG deferred restricted stock unit grant?

The grant is governed by Apogee’s 2019 Non-Employee Director Stock Plan. The plan provides for deferred restricted stock units, dividend equivalent reinvestment, and settlement terms that convert the units into common stock after Board service ends or other plan events occur.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/26/2026 - 01:04 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Alvord Christina M

(Last) (First) (Middle)

C/O APOGEE ENTERPRISES, INC.

4400 WEST 78TH STREET, SUITE 520

(Street)

MINNEAPOLIS MINNESOTA 55435

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
APOGEE ENTERPRISES, INC. [ APOG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferrred Restricted Stock Units(1)	(2)	06/24/2026		A		2,741		(1)	(1)	Common Stock	2,741	$41.96	13,280(3)	D

Explanation of Responses:

1. The deferred restricted stock units were allocated under the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person or following the occurrence of other events specified in the Plan.

2. Settled 1-for 1.

3. Includes deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2019 Non-Employee Director Stock Plan.

Remarks:

	/s/Bryan A. Welp, Attorney-in-Fact for Christina M. Alvord	06/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)